OpGen (Gaithersburg, MD) a commercial-stage genomics device company focused on optical mapping combining strain typing and sequencing, closed a $17M Series B round financing. Participants include jVen Capital, CHL Medical Partners, Highland Capital Partners, Mason Wells Biomedical and Versant Ventures.